1 Three cannabinoid receptor agonists, anandamide (CB 1 receptor-selective) and the aminoalkylindoles, JWH 015(2-methyl-1-propyl-1H-indol-3-yl)-1-napthalenylmethanone; (CB 2 receptor-selective), R-(+)-WIN 55,212-2 (R-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolol[1,2,3-de]-1,4-benzoxazin-6-yl]-1-napthalenylmethanone; slightly CB 2 receptor-selective), as well as the enantiomer S-(À)-WIN 55,212-3(S-(À)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolol[1,2,3-de]-1,4-benzoxazin-6-yl]-1-napthalenylmethanone; inactive at cannabinoid receptors), induced endotheliumindependent relaxation of methoxamine-precontracted isolated small mesenteric artery of rat. KCL (60 mM) precontraction did not affect relaxation to the aminoalkylindoles, but reduced that to anandamide. . These inhibitory effects were greatly reduced or abolished in ionomycin-(a calcium ionophore) contracted vessels. Anandamide also caused vanilloid receptorindependent, SR 141716A-(3 mM) insensitive, inhibition of CaCl 2 contractions. 5 In conclusion, the aminoalkylindoles JWH 015, R-(+)-WIN 55,212-2 and S-(À)-WIN 55,212-3 relax rat small mesenteric artery mainly by inhibiting Ca 2+ influx into vascular smooth muscle. Anandamide causes vasorelaxation by activating vanilloid receptors, but may also inhibit Ca 2+ entry. Relaxation to JWH 015 and anandamide was sensitive to SR 141716A, but there is no other evidence for the involvement of CB 1 or CB 2 receptors in responses to these compounds.